Papers
4
Total Citations
426
H-Index
3
About
Xiangmei Gu is a health services researcher whose work has shaped our understanding of the real-world costs and outcomes of surgical innovation, particularly in prostate cancer care. Her research focuses on the intersection of health economics, surgical technology adoption, and perioperative outcomes. Gu’s landmark 2011 study on the cost implications of rapidly adopting newer technologies for treating prostate cancer—cited over 300 times—revealed that costlier alternatives like intensity-modulated radiation therapy and robotic prostatectomy were being adopted without clear evidence of superior outcomes, providing critical data for value-based care discussions. She also led a national analysis of Medicare data tracking temporal trends in minimally invasive versus open radical prostatectomy outcomes from 2003 to 2007, demonstrating how surgeon volume affects patient results. Beyond urologic oncology, Gu has examined surgical approaches for complex gynecologic cases, such as myomectomy for extreme myoma burden. Her work has been instrumental in informing policy, clinical guidelines, and shared decision-making, highlighting the importance of balancing technological enthusiasm with evidence-based practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4